- Alexander DJ.A review of avian influenza in different bird species. Vet Microbiol2000;74:3–13.
- Guan Y, Smith GJ, Webby R, Webster RG.Molecular epidemiology of H5N1 avian influenza. Rev Sci Tech2009;28:39–47.
- Lvov DK, Shchelkanov MY, Prilipov AGet al.Evolution of highly pathogenic avian influenza H5N1 virus in natural ecosystems of northern Eurasia (2005–08). Avian Dis2010;54 (Suppl):483–495.
- Malik Peiris JS.Avian influenza viruses in humans. Rev Sci Tech2009;28:161–173.
- Kurtz J, Manvell RJ, Banks J.Avian influenza virus isolated from a woman with conjunctivitis. Lancet1996;348:901–902.
- Taylor HR, Turner AJ.A case report of fowl plague keratoconjunctivitis. Br J Ophthalmol1977;61:86–88.
- Webster RG, Geraci J, Petursson G, Skirnisson K.Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med1981;304:911.
- Fouchier RA, Schneeberger PM, Rozendaal FWet al.Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA2004;101:1356–1361.
- Lipatov AS, Webby RJ, Govorkova EA, Krauss S, Webster RG.Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis2005;191:12160–12120.
- Subbarao K, Chen H, Swayne Det al.Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology2003;305:192–200.
- Webby RJ, Perez DR, Coleman JSet al.Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet2004;363:1099–1103.
- Min JY, Vogel L, Matsuoka Yet al.A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol2010;84:11950–11960.
- Talaat KR, Karron RA, Callahan KAet al.A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine2009;27:3744–3753.
- Gao W, Soloff AC, Lu Xet al.Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol2006;80:1959–1964.
- Swayne DE.Application of new vaccine technologies for the control of transboundary diseases. Dev Biol (Basel)2004;119:219–228.
- Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Vaccine2007;25:7379–7384.
- Tian G, Zhang S, Li Yet al.Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology2005;341:153–162.
- Chen H.Avian influenza vaccination: the experience in China. Rev Sci Tech2009;28:267–274.
- Klenk HD, Garten W.Host cell proteases controlling virus pathogenicity. Trends Microbiol1994;2:39–43.
- Gabriel G, Garn H, Wegmann Met al.The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine. Vaccine2008;26:956–965.
- Stech J, Garn H, Wegmann M, Wagner R, Klenk HD.A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nat Med2005;11:683–689.
- Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J.The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci USA2005;102:18590–18595.
- Wagner R, Herwig A, Azzouz N, Klenk HD.Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity. J Virol2005;79:6449–6458.
- Neumann G, Watanabe T, Ito Het al.Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA1999;96:9345–9350.
- OIE. On avian influenza: manual of diagnostic tests and vaccines.Paris: OIE, 2009. Available at http://web.oie.int/eng/normes/mmanual/2008/pdf/2.03.04_AI.pdf (accessed 17 January 2013).
- Stieneke-Grober A, Vey M, Angliker Het al.Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J1992;11:2407–2414.
- Feldmann A, Schafer MK, Garten W, Klenk HD.Targeted infection of endothelial cells by avian influenza virus A/FPV/Rostock/34 (H7N1) in chicken embryos. J Virol2000;74:8018–8027.
- Rott R, Reinacher M, Orlich M, Klenk HD.Cleavability of hemagglutinin determines spread of avian influenza viruses in the chorioallantoic membrane of chicken embryo. Arch Virol1980;65:123–133.
- Scheiblauer H, Kendal AP, Rott R.Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol1995;140:341–348.
- Klenk HD, Rott R, Orlich M, Blodorn J.Activation of influenza A viruses by trypsin treatment. Virology1975;68:426–439.
- Klenk HD, Garten W, Matrosovich M.Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: lessons from the 2009 pandemic. Bioessays2011;33:180–188.
- Neumann G, Kawaoka Y.Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis2006;12:881–886.
- Steinhauer DA.Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology1999;258:1–20.
- Bogs J, Veits J, Gohrbandt Set al.Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS ONE2010;5:e11826.
- Stech O, Veits J, Weber Set al.Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain. J Virol2009;83:5864–5868.
- Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC.Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell1998;95:409–417.
- Robertson JS, Engelhardt OG.Developing vaccines to combat pandemic influenza. Viruses2010;2:532–546.
- World Health Organisation. WHO guidance on development of influenza vaccine reference viruses by reverse genetics. Geneva: WHO, 2012. Available at http://www.who.int/vaccine_research/diseases/influenza/WHO_guidance_on_development_of_influenza_vaccine_reference_viruses_by_RG_2005_6.pdf (accessed 24 July 2012).
- Glezen WP.Cell-culture-derived influenza vaccine production. Lancet2011;377:698–700.
- Minor PD, Engelhardt OG, Wood JMet al.Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine2009;27:2907–2913.
- Minor PD.Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clin Infect Dis2010;50:560–565.
Emerging Microbes & Infections
Volume 2, 2013 - Issue 1